Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group

BACKGROUND: The palliative role of chemoradiation in the treatment of patients with locally advanced, inoperable non-small-cell lung cancer stage III and negative prognostic factors remains unresolved. METHODS: Patients not eligible for curative radiotherapy were randomised to receive either chemora...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Strøm, H H, Bremnes, R M, Sundstrøm, S H, Helbekkmo, N, Fløtten, Ø, Aasebø, U
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2013
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776981/
https://ncbi.nlm.nih.gov/pubmed/23963145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.466
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars